Belzutifan is a pharmaceutical raw material that acts as an inhibitor of hypoxia-inducible factor 2α (HIF-2α). It is used in research and manufacturing related to certain cancer pathways, particularly those associated with von Hippel-Lindau disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Belzutifan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Tropine benzylate hydrochloride
pharmaceutical raw material
Ornidazole
pharmaceutical raw material
Desmopressin diacetate
pharmaceutical raw material
Flibanserin
pharmaceutical raw material
HIF-2alpha-IN-2
research compound
3-[[(1S)-7-(difluoromethylsulfonyl)-2,2-difluoro-1-hydroxy-1,3-dihydroinden-4-yl]oxy]-5-fluorobenzonitrile
research compound
The international HS code for Belzutifan (CAS 1672668-24-4) is 2930.90.
2930.90
2930 90 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3-[[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]oxy]-5-fluorobenzonitrile
LOMMPXLFBTZENJ-ZACQAIPSSA-N
CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O
Sourcing Belzutifan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.